Ezabenlimab

DB17483Investigational

Ezabenlimab: Overview.

Mechanism
Curator reviewed
Also known as
Anti-pd-1 monoclonal antibody bi 754091 · Immunoglobulin g4 (228-proline), anti-(human programmed cell death protein 1) (human monoclonal bi754091 .gamma.4-chain), disulfide with human monoclonal bi754091 .kappa.-chain, dimer
Code names
BI-754091

Resolves to

Compound
UNII5V1UI86573CAS2249882-54-8
Targets
Q15116PDCD1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
25Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ezabenlimab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In